The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. Is BPC 157 Legal? Understanding Its Status and Implications An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica The Peptide Boom Is Getting Out of Hand The Atlantic